Related references
Note: Only part of the references are listed.Influence of surface characteristics of modified glass beads as model carriers in dry powder inhalers (DPIs) on the aerosolization performance
Sarah Zellnitz et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2015)
Dry powder inhalers: Physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol
Waseem Kaialy et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Improved delivery of the natural anticancer drug tetrandrine
Chen Shi et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: solid-state characterization and aerosol dispersion performance
Jafar Ezzati Nazhad Dolatabadi et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2015)
Influence of Surface Chemistry on Cytotoxicity and Cellular Uptake of Nanocapsules in Breast Cancer and Phagocytic Cells
Ibrahima Youm et al.
AAPS JOURNAL (2014)
Agglomerates and aggregates of nanoparticles made in the gas phase
Maximilian L. Eggersdorfer et al.
ADVANCED POWDER TECHNOLOGY (2014)
Pure insulin highly respirable powders for inhalation
Anna Giulia Balducci et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Physicochemical characterization and aerosol dispersion performance of organic solution advanced spray-dried microparticulate/nanoparticulate antibiotic dry powders of tobramycin and azithromycin for pulmonary inhalation aerosol delivery
Xiaojian Li et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Preparation, Evaluation and Need of Spherical Crystallization in Case of High Speed Direct Tabletting
Suneel Pandey et al.
CURRENT DRUG DELIVERY (2014)
Application of the combinative particle size reduction technology H 42 to produce fast dissolving glibenclamide tablets
Jaime Salazar et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Characterization and aerosol dispersion performance of advanced spray-dried chemotherapeutic PEGylated phospholipid particles for dry powder inhalation delivery in lung cancer
Samantha A. Meenach et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Formulation of pyrazinamide-loaded large porous particles for the pulmonary route: Avoiding crystal growth using excipients
Dinh-Duy Pham et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Aerodynamic dose emission characteristics of dry powder inhalers using an Andersen Cascade Impactor with a mixing inlet: The influence of flow and volume
Sani Ibn Yakubu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
Drug-lactose binding aspects in adhesive mixtures: Controlling performance in dry powder inhaler formulations by altering lactose carrier surfaces
Qi (Tony) Zhou et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Design and evaluation of poly(DL-lactic-co-glycolic acid) nanocomposite particles containing salmon calcitonin for inhalation
Mingshi Yang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Brain targeting with surface-modified poly(D,L-lactic-co-glycolic acid) nanoparticles delivered via carotid artery administration
Kohei Tahara et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2011)
The impact of electrostatic charge in pharmaceutical powders with specific focus on inhalation-powders
Stefan Karner et al.
JOURNAL OF AEROSOL SCIENCE (2011)
Preparation and in vitro Characterization of Porous Carrier-Based Glipizide Floating Microspheres for Gastric Delivery
N. Pandya et al.
JOURNAL OF YOUNG PHARMACISTS (2011)
Influence of Stabilizers on the Physicochemical Characteristics of Inhaled Insulin Powders Produced by Supercritical Antisolvent Process
Yong Ho Kim et al.
PHARMACEUTICAL RESEARCH (2009)
Cyclodextrins as stabilizers for the preparation of drug nanocrystals by the emulsion solvent diffusion method
Abdallah Makhlof et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2008)
Improved compaction and packing properties of naproxen agglomerated crystals
M. Maghsoodi et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2007)
Freeze-drying of nanoparticles: Formulation, process and storage considerations
Wassim Abdelwahed et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Formulation and characterization of lipid-coated tobramycin particles for dry powder inhalation
Gabrielle Pilcer et al.
PHARMACEUTICAL RESEARCH (2006)
DNA nano-carriers from biodegradable cationic branched polyesters are formed by a modified solvent displacement method
CG Oster et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Inhaler treatment options in COPD
S. P. Newman
EUROPEAN RESPIRATORY REVIEW (2005)
SCF-engineered powders for delivery of budesonide from passive DPI devices
JM Lobo et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2005)
Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions
H Yamamoto et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Alternative sugars as potential carriers for dry powder inhalations
H Steckel et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications
NR Labiris et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)
Dissolution rate enhancement by in situ micronization of poorly water-soluble drugs
N Rasenack et al.
PHARMACEUTICAL RESEARCH (2002)
The role of particle properties in pharmaceutical powder inhalation formulations
NYK Chew et al.
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG (2002)
Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study
J Vandervoort et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Quantification of low levels (<10%) of amorphous content in micronised active batches using dynamic vapour sorption and isothermal microcalorimetry
L Mackin et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2002)
Mucoadhesive nanoparticulate systems for peptide drug delivery
H Takeuchi et al.
ADVANCED DRUG DELIVERY REVIEWS (2001)
Share Paper
